Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Here's Why the Best Is Yet to Come For HCP

By Matthew Frankel, CFP® - Mar 10, 2017 at 1:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

HCP continues to improve, which should put it in a great position to capitalize in the coming years.

Healthcare real estate investment trust HCP, Inc. ( PEAK 0.59% ) has undergone a big transformation over the past year or so, and the result of these efforts is a much more stable, high-quality, and financially flexible company. However, the work isn't done yet -- the best could still be yet to come for HCP's shareholders.

The "new" HCP

By far, the most significant event that took place within HCP during 2016 was the spin-off of the HCR ManorCare portfolio of assets into a newly created REIT, known as Quality Care Properties ( QCP ), or simply as QCP for short.

In addition, HCP decided to sell a significant amount of other properties in order to reduce its exposure to Brookdale Senior Living as a tenant. Lack of tenant diversification is a big risk factor for several major healthcare REITs, and HCP reducing its Brookdale concentration from 34% to 27% is a positive step in the right direction.

Nurse assisting elderly patient.

Image source: Getty Images.

Because of these transactions, HCP now has a much higher asset quality, as the portfolio is primarily composed of predictable, private-pay healthcare properties. Private-pay is generally more stable than properties dependent on government reimbursement programs, and HCP's portfolio is now 94% private-pay, and is spread out among senior housing, medical office, and life science property types.

Also, the company is more financially sound than it was a year ago. Thanks to debt repayments that resulted from the spin-off proceeds, HCP has no significant debt maturities through the end of 2018. Plus, the company has done an excellent job of reducing the interest rates on its debt, while maintaining long-dated maturities and avoiding floating-rate debt.

Chart of HCP's debt metrics over time.

Image source: HCP Investor Presentation.

HCP's 2019 goals

One of HCP's primary goals is to regain its Baa1/BBB+ credit ratings, which it lost some time ago.

To achieve this goal, HCP intends to dramatically improve its financial condition over the next few years, and reduce its tenant concentration even further.

Metric

End of 2016

2017 Target

2019 Target

Net Debt/EBITDA

6.2x

Low- to mid-6x

5.5x-6.0x

Leverage

48.6%

43%-44%

Less than 40%

Fixed-Charge Coverage

3.6x

3.6x-3.8x

More than 3.5x

Top 3 Tenant Concentration

44%

35%-40%

30%-35%

Source: HCP Investor Presentation.

HCP also expects to increase its re-development pipeline in order to maximize returns. In the near term, HCP anticipates $75-$100 million of re-development projects per year, with a cash-on-cost return in the 9%-12% range -- significantly higher than the company can expect from simply buying an existing property.

HCP will be in a strong position to capitalize on the growing healthcare market

There are a few reasons to be bullish on healthcare real estate, both in the intermediate-term and over the next several decades.

For starters, the U.S. population is aging -- fast. Over the next 20 years, 10,000 people will turn 65 in the United States every day, and the 75-and-over population is expected to roughly double over the next 20 years. This translates to an expected surge in healthcare demand, especially for senior housing facilities, HCP's bread-and-butter.

Additionally, the healthcare real estate market is highly fragmented and is in the early stages of REIT consolidation. The existing inventory of healthcare properties in the U.S. is estimated to be worth about $1.1 trillion, and even the largest REITs have a market share of about 3%. In all, less than 15% of healthcare real estate is REIT-owned (compared with 40% or more for properties like hotels and malls), so there is ample opportunity for growth within the existing inventory.

HCP's portfolio composition, and the overall healthcare RE market.

Image source: HCP Investor Presentation.

Invest with the long term in mind

As a final point, healthcare real estate is an inherently defensive type of asset. It is a non-discretionary type of commercial business, which means it generally holds up just fine during recessions and other tough times. Plus, most healthcare tenants are on long-term net leases with 2%-3% annual rent increases build right in.

Having said that, this doesn't mean that HCP is immune to volatility along the way. There are several factors that could send shares on a roller-coaster ride, such as interest rate fluctuations and political uncertainty in the healthcare industry.

The point is that REITs like HCP should be approached as long-term investments. Over the long term, HCP's business model should generate excellent returns, but not without a few bumps in the road along the way, so invest accordingly.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HCP, Inc. Stock Quote
HCP, Inc.
PEAK
$34.28 (0.59%) $0.20
Quality Care Properties Stock Quote
Quality Care Properties
QCP

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
633%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/07/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.